Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs

N Engl J Med. 2021 Aug 12;385(7):628-639. doi: 10.1056/NEJMra1909094.

Authors

Georg Schett¹, Iain B McInnes¹, Markus F Neurath¹

Affiliation

¹ From the Departments of Medicine 3 (G.S.) and Medicine 1 (M.F.N.) and Deutsches Zentrum Immuntherapie (G.S., M.F.N.), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany; and the College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom (I.B.M.).

PMID: 34379924
DOI: 10.1056/NEJMra1909094

No abstract available

Publication types

Review

MeSH terms

Arthritis, Psoriatic / drug therapy
Arthritis, Psoriatic / immunology
Arthritis, Rheumatoid / immunology
Autoimmune Diseases / drug therapy
Autoimmune Diseases / immunology*
Cytokines / immunology
Humans
Immune System Diseases
Inflammation / immunology*
Inflammatory Bowel Diseases / immunology
Interleukins / antagonists & inhibitors
Interleukins / immunology*
Janus Kinase Inhibitors / therapeutic use
Spondylarthritis / immunology

Substances

Cytokines
Interleukins
Janus Kinase Inhibitors